Walker's Research Business Information
A publisher of Business Information since 1983  
Search Business Search Executive   Advanced Search
 |  Sign In  |  Hints
Company Name Amgen Inc. Ticker Symbol AMGN

 Address 1 Amgen Ctr. Dr.
Thousand Oaks, CA 91320
United States
Email investor.relations@amgen.com Phone 1-805-447-1000
Website www.amgen.com Fax 1-805-447-1010

Business Information

The group's principal activities are to discover, develop, manufacture and market human therapeutics based on advances in cellular and molecular biology. The group markets human therapeutic products in the areas of hematology, oncology, and inflammation. The group's key products include epogen(R), aranesp(R), neulasta(R), neupogen(R), enbrel(r). Epogen(R) and aranesp(R) stimulate the production of red blood cells, for the treatment of anemia associated with chronic renal failure. Neulasta(R) and neupogen(R) selectively stimulate the production of neutrophils, one type of white blood cell, for treatment of infection in-patients undergoing myelosuppressive chemotherapy. Enbrel(R) blocks the biologic activity of tumor necrosis factor, which is used for treating patients with active rheumatoid arthritis. The group's other products include kineret(R) and stemgen(r). It maintains a sales and marketing force in the United States, Europe, Canada, Australia, and New Zealand.

Executive Information
Name Title Email
Kevin SharerChmn., CEO, Pres. N/A
Robert BradwayCFO, Exec. VP N/A
Brian McNameeSr. VP - Human Resources N/A
Fabrizio BonanniExec. VP - Operations N/A
George MorrowExec. VP - Global Commercial Operations N/A

Financial Information  ( All figures in $ '000 )
Year Sales Net Income
2006 14,268,0002,950,000
2005 12,430,0003,674,000
2004 10,550,0002,363,000

Click for more Executives

            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.